REVELATION BIOSCIENCES, INC. - Common stock, par value $0.001 per share (REVB) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2025 to Q4 2025

Type / Class
Equity / Common stock, par value $0.001 per share
Symbol
REVB on Nasdaq
Shares outstanding
5,778,196
Price per share
$0.52
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
1,230,544
Total reported value
$983,945
% of total 13F portfolios
0%
Share change
+850,447
Value change
+$622,248
Number of holders
11
Price from insider filings
$0.52
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of REVELATION BIOSCIENCES, INC. - Common stock, par value $0.001 per share (REVB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SABBY MANAGEMENT, LLC 9.6% $502,733 605,702 SABBY MANAGEMENT, LLC 31 Dec 2025
ARMISTICE CAPITAL, LLC 5% -50% $149,933 +$19,540 288,332 +15% Armistice Capital, LLC 31 Dec 2025

As of 31 Dec 2025, 11 institutional investors reported holding 1,230,544 shares of REVELATION BIOSCIENCES, INC. - Common stock, par value $0.001 per share (REVB). This represents 21% of the company’s total 5,778,196 outstanding shares.

Top 16 Institutional Shareholders

The largest institutional shareholders of REVELATION BIOSCIENCES, INC. - Common stock, par value $0.001 per share (REVB) together control 21% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
SABBY MANAGEMENT, LLC 10% 605,702 +193% 4% $484,440
ARMISTICE CAPITAL, LLC 7.5% 434,272 +443% 0.01% $347,331
CITADEL ADVISORS LLC 0.95% 54,728 0% $43,771
VANGUARD GROUP INC 0.91% 52,505 0% $42,004
GEODE CAPITAL MANAGEMENT, LLC 0.59% 34,019 0% $27,207
NORTHERN TRUST CORP 0.38% 21,907 0% $17,521
HRT FINANCIAL LP 0.27% 15,320 0% $12,000
XTX Topco Ltd 0.2% 11,319 0% $9,053
UBS Group AG 0.01% 724 +36100% 0% $579
BANK OF AMERICA CORP /DE/ 0% 47 +236% 0% $38
DANSKE BANK A/S 0% 1 0% 0% $1
CITIGROUP INC 0% 0 -100% $0
Tower Research Capital LLC (TRC) 0% 0 -100% $0
SBI Securities Co., Ltd. 0% 0 -100% $0
JANE STREET GROUP, LLC 0% 0 -100% $0
DRW Securities, LLC 0% 0 -100% $0

Institutional Holders of REVELATION BIOSCIENCES, INC. - Common stock, par value $0.001 per share (REVB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,230,544 $983,945 +$622,248 $0.80 11
2025 Q3 380,097 $539,736 +$537,763 $1.42 10
2025 Q2 1,390 $1,043 +$1,043 $0.75 1